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doi:10.1016/j.jmii.2011.09.008Aeromonas hydrophila septicemia has a fulminant course and it has been usually reported in
immunocompromised hosts and rarely among children with leukemia. High morbidity and
mortality is associated with A hydrophila infections. We describe the case of a child with acute
lymphoblastic leukemia who presented with septicemia due to A hydrophila. The patient pre-
sented with fever and skin discoloration during a febrile neutropenia episode, which rapidly
evolved into bacteremia and extensive thigh suppuration, fasciitis, and myonecrosis. Apart
from antibiotic treatment, surgical debridement to relieve compartment pressure and prevent
further lower extremity compromise was promptly performed. Despite long delays in chemo-
therapy and an extensive tissue gap, primary closure of the involved area was possible with full
cosmetic and functional limb recovery, and the patient has remained in clinical remission for
more than 7 years.
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Aeromonas species are gram-negative, nonsporulating
facultative anaerobic rods that produce b-lactamase. The
most common species responsible for human infection is
Aeromonas hydrophila.1 These pathogens are widely
distributed in the aquatic environment (fresh and saltished by Elsevier Taiwan LLC. All rights reserved.
A hydrophila infection in a patient with leukemia 155water) and in chlorinated tap water, including hospital
water supplies.
A hydrophila causes soft tissue infections in non-
immunocompromised hosts, usually after local trauma,
leech therapy, or surgery.2 Similar complications have been
described in patients with neutropenic cancer, mainly after
chemotherapy for acute leukemia.3 A. hydrophila aerolysin
is a pore-forming toxin that can contribute to cell death
and clinical onset of suppuration and myonecrosis, with or
without gas formation.4
In the present study, we report the case of a child with
acute lymphoblastic leukemia (ALL) who developed fulmi-
nant septicemia due to A hydrophila infection as the
presentation of a febrile episode during neutropenia. The
patient presented with gangrenous lesions with necrosis of
the skin of the thigh and eventually developed extensive
thigh suppuration, fasciitis, and myonecrosis. Immediate
antimicrobial administration and prompt surgical interven-
tion resulted in the patient’s excellent cosmetic and func-
tional outcome, even in this case of extensive tissue damage.Case presentation
A girl 2.5 year of age was diagnosed with ALL. On admission
to our unit, she was afebrile and pale, with a good level of
consciousness. Initial complete blood count (CBC) revealed
white blood cells (WBC), 20.18 109/L with 50% L1
morphology blasts, Hb 4.8 g/dL, Ht 10.0%, and PLT
101 109/L. Serum biochemical profile was normal. The
patient was found to have CD10þ B-cell ALL, TEL/AMLþ, so
she was assigned to the median risk ALL group and treated
according to the ALL-BFM-95 protocol. She responded
favorably to 8 days of prednisolone and n dayþ 15 blasts
were not detected by microscopy or flow cytometry.
On the 18th day of treatment, the patient presented with
a high fever of 39C and rigors. Physical examination was
normal, apart from a nonspecific hip pain that progressed to
the inner left thigh. She had no diarrhea. The CBC revealed
very severe neutropenia (absolute neutrophil count,
<0.1 109/L, Hb 11.1 g/dL, Ht 33.7% and PLT 45 109/L. A
deep violet rash and skin infiltration with a purplish discol-
oration over the inner thighwas evident, which progressed to
a gangrenous lesionwith apparent skin necrosis. Hip and thigh
plain x-rays did not reveal any bony lesions, but soft tissue gas
formation into the inner aspect of themid and proximal thigh
was evident by plain x-rays and computerized tomography
(Fig. 1E,1F). Ultrasound and computed tomography of the
area showed the similar findings.11 Technicium bone scan
displayed no bone involvement. Piperacillin with tazobactam
and amikacin intravenously together with fluconazole PO
were commenced immediately. The ALL induction treatment
was withheld, with the exception of prednisolone.
The patient’s clinical condition deteriorated within the
following 2 days; her body temperature was 38.5C, but she
had no signs of septic shock. The blood cultures revealed
a gram-negative organism, but in vitro sensitivities were
not available at this point. The treatment was modified to
cefepime, tobramycin, and liposomal amphotericin, since
the gangrene was extending apart from the skin and the
underlying soft tissues to the vulva (Fig. 1A). In addition,
edema and skin discoloration were evident.The main concern was whether surgical dissection of the
extensive necrotic tissue would be the optimal intervention
at that point or whether it would create amajor tissue deficit
and, consequently, difficulty in healing. In the meantime,
blood cultures revealedAhydrophila, identifiedwith theAPI-
20E (BioMe´rieux, France) identification system. Following
the Kirby-Bauer methodology and the Clinical Laboratory
Standards Institute interpretation criteria, the antibiogram
showed sensitivity to cefoxitin, cefotaxime, aztreonam,
imipenem, meropenem, cefepime, gentamicin, tobramycin,
amikacin, netilmicin, resistance to cephalothin and co-
trimoxazole, and intermediate sensitivity to amoxicillin/
clavulanic acid and ticarcillin/clavulanic acid. Stool cultures
did not reveal any pathogen.
In the meantime, the patient’s clinical condition was not
improving, and she presented signs of septicemia, tachyp-
nea, hypotension, impaired level of communication, and
apparent blood gas abnormalities. Considering her clinical
presentation and the major extension of the necrosis to the
inner thigh and the muscles, a surgical intervention was
decided. The skin, underlying muscles, and the surrounding
necrotic soft tissues were removed and careful debride-
ment of the inner aspect of the left thigh was undertaken.
Compartment pressure was relieved. This created a skin
gap of 21 11 cm. The underlying muscles were visible and
the area of the vulva on the ipsilateral side was practically
detached from the pelvic structures (Fig. 1B).
Additionally, granulocyte colony-stimulating factor was
administered for 5 days since the patient was neutropenic.
Daily tissue debridement and a local application of Alkanna
tinctoria extract ointment were initiated to promote heal-
ing. Supportive care included passive and active physical
activity in the context of a rehabilitation program.
The patient underwent deeper and more extensive local
tissue care under anesthesia three more times. All necrotic
muscles, fat, and skin tissues were removed, and an open
granulating wound from the underlying structures was
evident. The treatment plan was to repair and cover the
gap with a homologous skin graft. However, 15 days from
the initial surgery it was apparent that suturing the edges
posed an acceptable tension to the skin. Thus, we pro-
ceeded with suturing of the area, without any graft
implantation (Fig. 1C). The patient received cefepime and
tobramycin for 22 and 20 days, respectively.
Twenty days following the presentation of A hydrophila
infection, the patient was still in clinical and morphological
remission. At present, she has completed chemotherapy
treatment and she remains in clinical and morphological
remission, 75 months after ALL diagnosis. The lower limb
has full functionality, without any disfiguration, apart from
a well-healed extensive surgical scar (Fig. 1D).Discussion
The cure rate for childhood ALL has significantly improved
over time, reaching approximately 85%. However,
infection-related morbidity and mortality continues to be
of great importance in immunocompromised patients,
with bacterial pathogens being the most common cause.5
Bacterial infections were the common cause of morbidity
during the induction phase. In a previous study of our
Figure 1. The patient’s inner left thigh at different time points: A: One day before surgery, B: Five days following surgery,
C: Following primary closure and suturing, D: Five months following surgery, E: Plain radiograph with evidence of gas formation
within the muscle compartments (arrow), F: Computerized tomography of the left thigh indicating swelling and disruption of the
anatomy of the posterior muscular structures with gas present within them (arrow), together with haziness and liquid collections of
the subcutaneous fat.
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an infection due to A hydrophila among children with
ALL.5
The Aeromonas species causes infections, such as
bacterial gastroenteritis, septicemia, peritonitis, hemolytic-
uremic syndrome, and respiratory tract diseases, especially
in immunocompromised hosts with malignant or hep-
atobiliary diseases.6 The majority of Aeromonas bacter-
emias reported in a series of 143 cases were in patients who
were immunocompromised, including 54% patients with
cirrhosis and 32% with an underlying malignancy.4 The status
of the immune system plays an important role in inducing
disease by this pathogen in the host. The high mortality rate
of Aeromonas bacteremias is noticeable among immuno-
compromised hosts, which ranges from 24% to 68%.4The Aeromonas species may also cause skin and soft
tissue infections, such as cellulitis, fasciitis, and myonec-
rosis with or without gas formation.1,2 They have also been
involved in cases of osteomyelitis.7 Septicemia may result
from contamination of wounds from fresh water or soil
sources.8
The most common portals of entry of A hydrophila in
patients with bacteremia include the gastrointestinal tract
and skin lesions resulting from traumatic injury.1,9 The dis-
integrated gastrointestinal mucosa resulting from cytotoxic
treatment is an important portal of entry in patients with
hematologic malignancies. Apart from higher gastrointes-
tinal tract colonization by Aeromonas, a subsequently higher
risk of diarrhea has been suggested in patients with neu-
tropeniawho also have hematologicmalignancies.9 However,
A hydrophila infection in a patient with leukemia 157a recent study suggested that Aeromonas-associated diar-
rhea was rare.10 Our patient presented no diarrhea.
In our patient, there was no evidence of trauma or other
mechanical impact in the physical examination. In addition,
there was no history of penetrating injury. Thus, it seems
more likely that A hydrophila had first colonized in the
gastrointestinal tract and then caused bacteremia during
neutropenia. The infection was then also localized to the
soft tissues of the thigh. Lin et al.10 proposed that the
gastrointestinal system might be the source through which
the pathogen reaches the circulatory system. Bacterial
translocation from the bowel was an important pathogen-
esis of infection in patients with cirrhosis.
Our patient lives by the coast of an island and the
family’s diet is rich in fish and homemade cheeses. It is
noticeable that she was infected by the pathogen in the
summer. Aeromonas species are found in fish and other
seafood, and they can survive in whey cheeses that are
consumed locally.11 However, the route of transmission
cannot be identified in all cases with concurrent underlying
disease.7
The clinical presentation of skin and soft tissue infec-
tions varies in patients with Aeromonas sepsis.2 In immu-
nocompromised hosts, soft tissue infections have been
documented even without evidence of local trauma or skin
lesion at the initial presentation.6
It is also significant that this was a single case of Aero-
monas infection in our unit and no other case was docu-
mented or reported with similar presentation. In addition, A.
hydrophila was not isolated from the water supplies in our
hospital. Thus, it was deduced that this infection was not
nosocomial. In the literature, it is reported that approxi-
mately one-third of Aeromonas infections are nosocomial.6
Our patient had a fulminant clinical course, presenting
initially with gangrene that progressed to fasciitis and
myonecrosis. However, she was treated immediately with
broad-spectrum antibiotics, which were modified when the
Aeromonas infection was documented. Furthermore, the
infection was successfully controlled due to the timely
surgical intervention. There is full function of the leg,
without disfiguring tissue deficits and the final cosmetic
result is more than acceptable.
Considering the high rate of opportunistic infections in
immunocompromised patients and the lack of specific
clinical signs of Aeromonas infections, the most active
empirical treatment interventions should consist of broad-
spectrum antibiotics or a fluoroquinolone combined with
gentamicin or amikacin in cases of severe infection.4,10In the present study we reported the case of a child with
ALL who developed skin and soft tissue infection due to A
hydrophila. The patient presented with nonspecific signs of
infection, had a nontraumatic skin lesion, and she was
neutropenic. The infection was finally well controlled and
the patient survived with excellent functionally of the limb.
The appropriate antimicrobial administration and the
timely surgical debridement of the area proved to be life
saving. Aeromonas infection must always be included in the
differential diagnosis of a gangrene-like tissue damage or
a skin lesion in patients with an underlying malignancy.References
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